Another investigation revealed that overexpression of Txn-1 and other Nrf2 regulated genes enabled breast cancer cells to become resistant to tamoxifen, a drug used for hormonal therapy in breast cancer [45]. This evidence concerns the gene TXN and breast carcinoma.